Medpace Quarterly Balance Sheets Chart
Quarterly
|
Annual
Medpace Quarterly Balance Sheets Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||||||||||||||||
current assets: | ||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 46,330,000 | 441,436,000 | 669,436,000 | 656,900,000 | 510,894,000 | 407,010,000 | 245,449,000 | 95,207,000 | 39,138,000 | 46,922,000 | 28,265,000 | 31,007,000 | 42,551,000 | 82,843,000 | 461,304,000 | 398,387,000 | 339,009,000 | 332,877,000 | 277,766,000 | 219,227,000 | 160,903,000 | 133,999,000 | 131,920,000 | 79,290,000 | 20,098,000 | 30,127,000 | 23,275,000 | 22,244,000 | 22,230,000 | 22,245,000 | 26,485,000 | 24,168,000 | 29,055,000 | 29,316,000 | 37,099,000 | 14,636,000 |
accounts receivable and unbilled | 377,921,000 | 298,217,000 | 296,443,000 | 311,466,000 | 301,108,000 | 279,166,000 | 298,400,000 | 292,773,000 | 275,058,000 | 257,746,000 | 253,404,000 | 249,086,000 | 225,695,000 | 224,759,000 | 186,432,000 | 186,378,000 | 161,489,000 | 159,997,000 | 160,962,000 | 134,087,000 | 127,286,000 | 136,374,000 | 155,662,000 | 140,189,000 | 149,860,000 | 129,624,000 | 133,449,000 | 108,285,000 | 115,398,000 | 110,654,000 | 83,079,000 | 74,708,000 | 76,664,000 | 82,283,000 | 79,767,000 | 81,922,000 |
prepaid expenses and other current assets | 96,554,000 | 81,784,000 | 63,350,000 | 64,229,000 | 60,521,000 | 58,726,000 | 49,979,000 | 60,901,000 | 64,731,000 | 62,954,000 | 52,293,000 | 57,648,000 | 60,641,000 | 48,367,000 | 43,176,000 | 56,455,000 | 49,602,000 | 40,506,000 | 34,923,000 | 41,691,000 | 30,893,000 | 32,629,000 | 29,446,000 | 30,918,000 | 24,386,000 | 22,624,000 | 21,383,000 | 22,549,000 | 20,844,000 | 20,848,000 | 20,400,000 | 18,074,000 | 17,129,000 | 16,433,000 | 16,074,000 | 20,606,000 |
total current assets | 520,805,000 | 821,437,000 | 1,029,229,000 | 1,032,595,000 | 872,523,000 | 744,902,000 | 593,828,000 | 448,881,000 | 378,927,000 | 367,622,000 | 333,962,000 | 337,741,000 | 328,887,000 | 355,969,000 | 690,912,000 | 641,220,000 | 550,100,000 | 533,380,000 | 473,651,000 | 395,005,000 | 319,082,000 | 303,002,000 | 317,028,000 | 250,397,000 | 194,344,000 | 182,375,000 | 178,114,000 | 153,085,000 | 158,479,000 | 153,754,000 | 129,971,000 | 117,029,000 | 123,123,000 | 128,325,000 | 133,248,000 | 120,527,000 |
property and equipment | 135,481,000 | 128,332,000 | 123,615,000 | 124,058,000 | 122,394,000 | 118,600,000 | 120,589,000 | 114,764,000 | 114,817,000 | 113,755,000 | 109,849,000 | 104,719,000 | 103,538,000 | 98,529,000 | 93,153,000 | 87,703,000 | 86,195,000 | 84,504,000 | 85,017,000 | 71,472,000 | 65,954,000 | 50,015,000 | 47,292,000 | 43,715,000 | 39,749,000 | 37,639,000 | 52,255,000 | 52,030,000 | 52,360,000 | 51,079,000 | 48,739,000 | 45,903,000 | 45,244,000 | 44,976,000 | 43,805,000 | 41,342,000 |
operating lease right-of-use assets | 129,504,000 | 129,859,000 | 128,649,000 | 130,547,000 | 134,001,000 | 138,803,000 | 144,801,000 | 144,147,000 | 139,863,000 | 143,309,000 | 139,068,000 | 139,071,000 | 135,389,000 | 141,638,000 | 129,558,000 | 125,428,000 | 110,730,000 | 112,266,000 | 113,809,000 | 109,533,000 | 113,566,000 | 58,667,000 | 52,152,000 | 52,479,000 | 51,809,000 | 53,627,000 | ||||||||||
goodwill | 662,396,000 | 662,396,000 | 662,396,000 | 662,396,000 | 662,396,000 | 662,396,000 | 662,396,000 | 662,396,000 | 662,396,000 | 662,396,000 | 662,396,000 | 662,396,000 | 662,396,000 | 662,396,000 | 662,396,000 | 662,396,000 | 662,396,000 | 662,396,000 | 662,396,000 | 662,458,000 | 662,427,000 | 662,427,000 | 662,396,000 | 662,427,000 | 662,427,000 | 662,380,000 | 660,981,000 | 660,981,000 | 660,981,000 | 660,981,000 | 660,981,000 | 660,981,000 | 660,981,000 | 660,981,000 | 660,981,000 | 660,981,000 |
intangible assets | 33,893,000 | 34,130,000 | 34,366,000 | 34,727,000 | 35,087,000 | 35,448,000 | 35,809,000 | 36,359,000 | 36,908,000 | 37,458,000 | 38,008,000 | 38,846,000 | 39,684,000 | 40,522,000 | 41,360,000 | 42,639,000 | 43,917,000 | 45,196,000 | 46,474,000 | 48,423,000 | 50,373,000 | 52,353,000 | 54,350,000 | 57,345,000 | 60,340,000 | 63,335,000 | 69,179,000 | 76,569,000 | 83,959,000 | 91,349,000 | 98,740,000 | 108,234,000 | 117,676,000 | 126,623,000 | 136,071,000 | 148,739,000 |
deferred income taxes | 65,792,000 | 99,692,000 | 100,357,000 | 76,683,000 | 75,196,000 | 75,231,000 | 74,435,000 | 59,343,000 | 51,766,000 | 49,157,000 | 48,083,000 | 27,023,000 | 26,441,000 | 25,809,000 | 25,134,000 | 1,272,000 | 540,000 | 556,000 | 536,000 | 477,000 | 469,000 | 490,000 | 376,000 | 293,000 | 313,000 | 330,000 | 713,000 | 446,000 | 5,972,000 | 9,970,000 | 6,343,000 | 11,115,000 | 11,536,000 | 154,000 | 97,000 | 135,000 |
other assets | 23,802,000 | 21,523,000 | 22,254,000 | 23,055,000 | 18,451,000 | 20,409,000 | 24,970,000 | 20,831,000 | 22,261,000 | 22,026,000 | 21,129,000 | 18,629,000 | 19,118,000 | 19,483,000 | 17,422,000 | 16,485,000 | 15,830,000 | 13,062,000 | 8,794,000 | 8,774,000 | 10,263,000 | 10,680,000 | 9,477,000 | 5,673,000 | 7,879,000 | 6,831,000 | 6,691,000 | 6,732,000 | 6,430,000 | 5,891,000 | 5,943,000 | 5,614,000 | 5,086,000 | 5,034,000 | 4,903,000 | 4,763,000 |
total assets | 1,571,673,000 | 1,897,369,000 | 2,100,866,000 | 2,084,061,000 | 1,920,048,000 | 1,795,789,000 | 1,656,828,000 | 1,486,721,000 | 1,406,938,000 | 1,395,723,000 | 1,352,495,000 | 1,328,425,000 | 1,315,453,000 | 1,344,346,000 | 1,659,935,000 | 1,577,143,000 | 1,469,708,000 | 1,451,360,000 | 1,390,677,000 | 1,296,142,000 | 1,222,134,000 | 1,137,634,000 | 1,143,071,000 | 1,072,329,000 | 1,016,861,000 | 1,006,517,000 | 967,933,000 | 949,843,000 | 968,181,000 | 973,024,000 | 950,717,000 | 948,876,000 | 963,646,000 | 966,093,000 | 979,105,000 | 976,487,000 |
liabilities and shareholders’ equity | ||||||||||||||||||||||||||||||||||||
current liabilities: | ||||||||||||||||||||||||||||||||||||
accounts payable | 43,275,000 | 61,318,000 | 32,528,000 | 26,201,000 | 27,388,000 | 24,402,000 | 31,869,000 | 29,023,000 | 33,608,000 | 37,110,000 | 33,069,000 | 28,245,000 | 28,800,000 | 25,434,000 | 25,678,000 | 25,052,000 | 23,326,000 | 21,348,000 | 26,552,000 | 15,878,000 | 14,879,000 | 16,985,000 | 22,404,000 | 20,684,000 | 22,691,000 | 13,626,000 | 16,737,000 | 13,602,000 | 16,859,000 | 17,924,000 | 16,674,000 | 9,972,000 | 7,195,000 | 8,345,000 | 10,911,000 | 9,337,000 |
accrued expenses | 323,505,000 | 286,099,000 | 307,807,000 | 306,868,000 | 292,659,000 | 270,926,000 | 292,961,000 | 264,785,000 | 231,925,000 | 201,201,000 | 210,125,000 | 204,117,000 | 173,192,000 | 155,018,000 | 159,286,000 | 158,211,000 | 145,847,000 | 123,608,000 | 134,367,000 | 116,996,000 | 102,950,000 | 107,005,000 | 109,252,000 | 102,535,000 | 93,604,000 | 82,247,000 | 87,493,000 | 80,328,000 | 72,925,000 | 63,576,000 | 23,673,000 | 20,085,000 | 16,392,000 | 14,083,000 | 24,417,000 | 21,415,000 |
advanced billings | 808,783,000 | 718,716,000 | 710,585,000 | 670,939,000 | 638,417,000 | 616,697,000 | 559,860,000 | 518,755,000 | 490,557,000 | 466,040,000 | 462,729,000 | 417,927,000 | 401,368,000 | 367,221,000 | 344,641,000 | 303,848,000 | 282,217,000 | 277,807,000 | 255,664,000 | 202,612,000 | 195,351,000 | 189,562,000 | 192,359,000 | 169,529,000 | 165,447,000 | 150,243,000 | 147,935,000 | 133,403,000 | 120,945,000 | 126,387,000 | 73,756,000 | 68,341,000 | 65,577,000 | 60,474,000 | 65,668,000 | 67,662,000 |
other current liabilities | 44,880,000 | 56,178,000 | 53,633,000 | 37,346,000 | 34,624,000 | 44,620,000 | 40,441,000 | 35,955,000 | 41,347,000 | 62,538,000 | 47,547,000 | 30,879,000 | 25,899,000 | 31,755,000 | 27,612,000 | 30,071,000 | 21,217,000 | 24,543,000 | 23,527,000 | 22,910,000 | 24,804,000 | 25,099,000 | 18,987,000 | 21,644,000 | 14,331,000 | 18,425,000 | 4,861,000 | 4,794,000 | 5,933,000 | 8,105,000 | 4,697,000 | 5,250,000 | 3,130,000 | 5,264,000 | 3,284,000 | 4,763,000 |
total current liabilities | 1,220,443,000 | 1,122,311,000 | 1,104,553,000 | 1,041,354,000 | 993,088,000 | 956,645,000 | 925,131,000 | 848,518,000 | 852,437,000 | 881,889,000 | 803,470,000 | 820,868,000 | 878,959,000 | 579,428,000 | 557,217,000 | 517,182,000 | 472,607,000 | 447,306,000 | 440,110,000 | 358,396,000 | 337,984,000 | 338,651,000 | 343,002,000 | 314,392,000 | 296,073,000 | 264,541,000 | 257,026,000 | 232,127,000 | 233,162,000 | 232,492,000 | 192,706,000 | 172,363,000 | 155,262,000 | 150,045,000 | 168,603,000 | 156,595,000 |
operating lease liabilities | 124,946,000 | 126,660,000 | 126,234,000 | 128,277,000 | 131,796,000 | 136,156,000 | 142,122,000 | 143,039,000 | 139,390,000 | 142,689,000 | 138,867,000 | 139,203,000 | 134,977,000 | 141,624,000 | 130,965,000 | 128,211,000 | 112,850,000 | 114,144,000 | 115,143,000 | 110,670,000 | 114,984,000 | 51,395,000 | 45,212,000 | 46,022,000 | 43,731,000 | 46,238,000 | ||||||||||
deferred income tax liability | 2,016,000 | 1,838,000 | 1,800,000 | 2,289,000 | 2,294,000 | 2,364,000 | 2,404,000 | 1,128,000 | 1,098,000 | 1,090,000 | 1,070,000 | 911,000 | 1,002,000 | 1,055,000 | 1,080,000 | 17,604,000 | 16,242,000 | 14,876,000 | 13,551,000 | 19,861,000 | 15,341,000 | 14,022,000 | 12,849,000 | 5,578,000 | 4,599,000 | 3,435,000 | 439,000 | 2,636,000 | 602,000 | 596,000 | 560,000 | 513,000 | 481,000 | 11,683,000 | 12,030,000 | 20,506,000 |
other long-term liabilities | 51,917,000 | 52,951,000 | 42,734,000 | 30,702,000 | 29,271,000 | 29,082,000 | 28,221,000 | 23,124,000 | 22,953,000 | 22,793,000 | 22,701,000 | 17,558,000 | 17,263,000 | 17,223,000 | 17,745,000 | 16,061,000 | 16,127,000 | 16,107,000 | 16,094,000 | 15,586,000 | 15,756,000 | 15,767,000 | 15,725,000 | 14,330,000 | 14,403,000 | 14,625,000 | 12,804,000 | 11,014,000 | 10,683,000 | 10,440,000 | 10,740,000 | 8,538,000 | 8,343,000 | 8,092,000 | 7,968,000 | 5,249,000 |
total liabilities | 1,399,322,000 | 1,303,760,000 | 1,275,321,000 | 1,202,622,000 | 1,156,449,000 | 1,124,247,000 | 1,097,878,000 | 1,015,809,000 | 1,015,878,000 | 1,048,461,000 | 966,108,000 | 978,540,000 | 1,032,201,000 | 739,330,000 | 707,007,000 | 679,058,000 | 617,826,000 | 592,433,000 | 584,898,000 | 504,513,000 | 484,065,000 | 419,835,000 | 416,788,000 | 380,322,000 | 358,806,000 | 384,620,000 | 378,230,000 | 388,454,000 | 428,100,000 | 461,951,000 | 447,187,000 | 398,626,000 | 356,288,000 | 345,113,000 | 368,395,000 | 365,947,000 |
commitments and contingencies | ||||||||||||||||||||||||||||||||||||
shareholders’ equity: | ||||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2025 and december 31, 2024 | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2025 and december 31, 2024; 28,088,626 and 30,630,799 shares issued and outstanding at june 30, 2025 and december 31, 2024, respectively | 281,000 | |||||||||||||||||||||||||||||||||||
treasury stock | -12,235,000 | -12,235,000 | -12,235,000 | -12,235,000 | -12,235,000 | -12,235,000 | -12,322,000 | -12,322,000 | -12,322,000 | -12,322,000 | -12,497,000 | -14,243,000 | -14,243,000 | -14,243,000 | -5,427,000 | -5,578,000 | -5,578,000 | -5,578,000 | -5,578,000 | -6,030,000 | -6,030,000 | -6,030,000 | -6,030,000 | -6,030,000 | -6,030,000 | -6,030,000 | -6,030,000 | -6,030,000 | -6,030,000 | -6,030,000 | -6,030,000 | |||||
additional paid-in capital | 893,174,000 | 886,883,000 | 844,050,000 | 836,903,000 | 818,903,000 | 814,649,000 | 802,681,000 | 795,994,000 | 785,292,000 | 778,691,000 | 770,794,000 | 759,986,000 | 753,300,000 | 746,123,000 | 727,857,000 | 721,597,000 | 716,547,000 | 707,877,000 | 695,904,000 | 687,618,000 | 676,621,000 | 673,372,000 | 666,585,000 | 663,044,000 | 651,784,000 | 643,497,000 | 639,381,000 | 636,536,000 | 634,469,000 | 632,374,000 | 630,341,000 | 628,558,000 | 627,407,000 | 625,296,000 | 623,629,000 | 622,071,000 |
(accumulated deficit) retained earnings | -703,215,000 | -269,716,000 | -359,827,000 | -380,115,000 | -446,142,000 | -120,812,000 | ||||||||||||||||||||||||||||||
accumulated other comprehensive loss | -5,654,000 | -11,621,000 | -14,743,000 | -9,176,000 | -12,589,000 | -12,041,000 | -10,072,000 | -12,870,000 | -11,194,000 | -11,314,000 | -12,392,000 | -16,052,000 | -9,972,000 | -6,388,000 | -4,846,000 | -3,243,000 | -1,760,000 | -2,266,000 | -131,000 | -2,123,000 | -3,223,000 | -3,729,000 | -2,741,000 | -3,663,000 | -2,377,000 | -2,791,000 | -2,517,000 | -2,179,000 | -2,115,000 | -105,000 | -734,000 | -1,263,000 | -2,028,000 | -3,146,000 | -3,742,000 | -2,375,000 |
total shareholders’ equity | 172,351,000 | 593,609,000 | 825,545,000 | 881,439,000 | 763,599,000 | 671,542,000 | 558,950,000 | 470,912,000 | 391,060,000 | 347,262,000 | 386,387,000 | 349,885,000 | 283,252,000 | 605,016,000 | 952,928,000 | 898,085,000 | 851,882,000 | 858,927,000 | 805,779,000 | 791,629,000 | 738,069,000 | 717,799,000 | 726,283,000 | 692,007,000 | 658,055,000 | 621,897,000 | 589,703,000 | 561,389,000 | 540,081,000 | 511,073,000 | 503,530,000 | 550,250,000 | 607,358,000 | 620,980,000 | 610,710,000 | 610,540,000 |
total liabilities and shareholders’ equity | 1,571,673,000 | 1,897,369,000 | 2,100,866,000 | 2,084,061,000 | 1,920,048,000 | 1,795,789,000 | 1,656,828,000 | 1,486,721,000 | 1,406,938,000 | 1,395,723,000 | 1,352,495,000 | 1,328,425,000 | 1,315,453,000 | 1,344,346,000 | 1,659,935,000 | 1,577,143,000 | 1,469,708,000 | 1,451,360,000 | 1,390,677,000 | 1,296,142,000 | 1,222,134,000 | 1,137,634,000 | 1,143,071,000 | 1,072,329,000 | 1,016,861,000 | 1,006,517,000 | 967,933,000 | 949,843,000 | 968,181,000 | 973,024,000 | 950,717,000 | 948,876,000 | 963,646,000 | 966,093,000 | 979,105,000 | 976,487,000 |
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2025 and december 31, 2024 | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2025 and december 31, 2024; 29,836,211 and 30,630,799 shares issued and outstanding at march 31, 2025 and december 31, 2024, respectively | 298,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at december 31, 2024 and 2023, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at december 31, 2024 and 2023, respectively; 30,630,799 and 30,752,292 shares issued and outstanding at december 31, 2024 and 2023, respectively | 306,000 | |||||||||||||||||||||||||||||||||||
retained earnings | 8,167,000 | 65,636,000 | 234,984,000 | 184,950,000 | 142,315,000 | 158,535,000 | 115,229,000 | 111,807,000 | 70,347,000 | 53,831,000 | 68,109,000 | 38,296,000 | 14,319,000 | |||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2024 and december 31, 2023 | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at september 30, 2024 and december 31, 2023; 31,081,601 and 30,752,292 shares issued and outstanding at september 30, 2024 and december 31, 2023, respectively | 311,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2024 and december 31, 2023 | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2024 and december 31, 2023; 31,001,549 and 30,752,292 shares issued and outstanding at june 30, 2024 and december 31, 2023, respectively | 310,000 | |||||||||||||||||||||||||||||||||||
accumulated deficit | -30,790,000 | -119,141,000 | -221,645,000 | -300,197,000 | -371,022,000 | -408,099,000 | -13,136,000 | -41,487,000 | -67,294,000 | -86,599,000 | -115,521,000 | -120,402,000 | -77,420,000 | -18,419,000 | -1,577,000 | -9,584,000 | -9,563,000 | |||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2024 and december 31, 2023 | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2024 and december 31, 2023; 30,983,185 and 30,752,292 shares issued and outstanding at march 31, 2024 and december 31, 2023, respectively | 310,000 | |||||||||||||||||||||||||||||||||||
short-term debt | 55,000,000 | 115,000,000 | 50,000,000 | 139,700,000 | 249,700,000 | |||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at december 31, 2023 and 2022, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at december 31, 2023 and 2022, respectively; 30,752,292 and 31,091,694 shares issued and outstanding at december 31, 2023 and 2022, respectively | 308,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2023 and december 31, 2022, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at september 30, 2023 and december 31, 2022, respectively; 30,682,157 and 31,091,694 shares issued and outstanding at september 30, 2023 and december 31, 2022, respectively | 307,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2023 and december 31, 2022, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2023 and december 31, 2022, respectively; 30,562,773 and 31,091,694 shares issued and outstanding at june 30, 2023 and december 31, 2022, respectively | 306,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2023 and december 31, 2022, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2023 and december 31, 2022, respectively; 30,623,655 and 31,091,694 shares issued and outstanding at march 31, 2023 and december 31, 2022, respectively | 306,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at december 31, 2022 and 2021, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at december 31, 2022 and 2021, respectively; 31,091,694 and 36,006,778 shares issued and outstanding at december 31, 2022 and 2021, respectively | 309,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2022 and december 31, 2021, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at september 30, 2022 and december 31, 2021, respectively; 31,098,397 and 36,006,778 shares issued and outstanding at september 30, 2022 and december 31, 2021, respectively | 309,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2022 and december 31, 2021, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2022 and december 31, 2021, respectively; 30,987,636 and 36,006,778 shares issued and outstanding at june 30, 2022 and december 31, 2021, respectively | 309,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2022 and december 31, 2021, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2022 and december 31, 2021, respectively; 33,651,360 and 36,006,778 shares issued and outstanding at march 31, 2022 and december 31, 2021, respectively | 336,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at december 31, 2021 and 2020, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at december 31, 2021 and 2020, respectively; 36,006,778 and 35,519,989 shares issued and outstanding at december 31, 2021 and 2020, respectively | 360,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2021 and december 31, 2020, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at september 30, 2021 and december 31, 2020, respectively; 35,939,191 and 35,519,989 shares issued and outstanding at september 30, 2021 and december 31, 2020, respectively | 359,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2021 and december 31, 2020, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2021 and december 31, 2020, respectively; 35,819,012 and 35,519,989 shares issued and outstanding at june 30, 2021 and december 31, 2020, respectively | 358,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2021 and december 31, 2020, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2021 and december 31, 2020, respectively; 35,926,158 and 35,519,989 shares issued and outstanding at march 31, 2021 and december 31, 2020, respectively | 359,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at december 31, 2020 and 2019, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at december 31, 2020 and 2019, respectively; 35,519,989 and 36,065,278 shares issued and outstanding at december 31, 2020 and 2019, respectively | 355,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2020 and december 31, 2019, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at september 30, 2020 and december 31, 2019, respectively; 35,757,453 and 36,065,278 shares issued and outstanding at september 30, 2020 and december 31, 2019, respectively | 357,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2020 and december 31, 2019, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2020 and december 31, 2019, respectively; 35,408,120 and 36,065,278 shares issued and outstanding at june 30, 2020 and december 31, 2019, respectively | 354,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2020 and december 31, 2019, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2020 and december 31, 2019, respectively; 35,484,473 and 36,065,278 shares issued and outstanding at march 31, 2020 and december 31, 2019, respectively | 355,000 | |||||||||||||||||||||||||||||||||||
restricted cash | 7,000 | 7,000 | 7,000 | 7,000 | 7,000 | 79,000 | 275,000 | 293,000 | 308,000 | 3,363,000 | ||||||||||||||||||||||||||
long-term debt, net, less current portion | 55,781,000 | 79,721,000 | 113,689,000 | 147,021,000 | 181,067,000 | 205,111,000 | 169,152,000 | 143,191,000 | 147,230,000 | 151,267,000 | 154,614,000 | |||||||||||||||||||||||||
deemed landlord liability, less current portion | 24,484,000 | 25,035,000 | 25,571,000 | 26,091,000 | 26,602,000 | 27,104,000 | 27,591,000 | 28,063,000 | 28,527,000 | 28,983,000 | ||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at december 31, 2019 and 2018, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at december 31, 2019 and 2018, respectively; 36,065,278 and 35,665,910 shares issued and outstanding at december 31, 2019 and 2018, respectively | 360,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at september 30, 2019 and december 31, 2018, respectively; 36,011,725 and 35,665,910 shares issued and outstanding at september 30, 2019 and december 31, 2018, respectively | 360,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2019 and december 31, 2018, respectively; 35,894,048 and 35,665,910 shares issued and outstanding at june 30, 2019 and december 31, 2018, respectively | 359,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2019 and december 31, 2018, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2019 and december 31, 2018, respectively; 35,728,989 and 35,665,910 shares issued and outstanding at march 31, 2019 and december 31, 2018, respectively | 357,000 | |||||||||||||||||||||||||||||||||||
pre-funded study costs | 57,406,000 | 53,246,000 | 48,530,000 | 48,473,000 | 51,948,000 | 53,418,000 | ||||||||||||||||||||||||||||||
current portion of long-term debt | 16,500,000 | 16,500,000 | 16,500,000 | 15,469,000 | 14,438,000 | 13,406,000 | 12,375,000 | |||||||||||||||||||||||||||||
deferred credit | 3,756,000 | 3,953,000 | 11,061,000 | 11,265,000 | 11,468,000 | 20,956,000 | 21,420,000 | |||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at december 31, 2018 and 2017, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at december 31, 2018 and 2017, respectively; 35,665,910 and 35,466,510 shares issued and outstanding at december 31, 2018 and 2017, respectively | 356,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2018 and december 31, 2017, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at september 30, 2018 and december 31, 2017, respectively; 35,587,848 and 35,466,510 shares issued and outstanding at september 30, 2018 and december 31, 2017, respectively | 356,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2018 and december 31, 2017, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2018 and december 31, 2017, respectively; 35,545,233 and 35,466,510 shares issued and outstanding at june 30, 2018 and december 31, 2017, respectively | 356,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2018 and december 31, 2017, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2018 and december 31, 2017, respectively; 35,504,675 and 35,466,510 shares issued and outstanding at march 31, 2018 and december 31, 2017, respectively | 355,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; 0 shares issued and outstanding at december 31, 2017 and 2016, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at december 31, 2017 and 2016, respectively; 35,466,510 and 40,662,856 shares issued and outstanding at december 31, 2017 and 2016, respectively | 355,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2017 and december 31, 2016, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at september 30, 2017 and december 31, 2016, respectively; 37,403,764 and 40,662,856 shares issued and outstanding at september 30, 2017 and december 31, 2016, respectively | 375,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2017 and december 31, 2016, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at june 30, 2017 and december 31, 2016, respectively; 39,692,999 and 40,662,856 shares issued and outstanding at june 30, 2017 and december 31, 2016, respectively | 398,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at march 31, 2017 and december 31, 2016, respectively | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares authorized at march 31, 2017 and december 31, 2016, respectively; 40,675,553 and 40,662,856 shares issued and outstanding at march 31, 2017 and december 31, 2016, respectively | 407,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at december 31, 2016; no shares authorized at december 31, 2015 | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares and 60,000,000 shares authorized at december 31, 2016 and 2015, respectively 40,662,856 and 32,624,461 shares issued and outstanding at december 31, 2016 and 2015, respectively | 407,000 | |||||||||||||||||||||||||||||||||||
preferred stock - 0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2016; no shares authorized at december 31, 2015 | ||||||||||||||||||||||||||||||||||||
common stock - 0.01 par-value; 250,000,000 shares and 60,000,000 shares authorized at september 30, 2016 and december 31, 2015, respectively; 40,716,410 and 32,624,461 shares issued and outstanding at september 30, 2016 and december 31, 2015, respectively | 407,000 |
We provide you with 20 years of balance sheets for Medpace stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Medpace. Explore the full financial landscape of Medpace stock with our expertly curated balance sheets.
The information provided in this report about Medpace stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.